Mombasa:The government has announced strategic reforms aimed at simplifying the cancer treatment process by removing the need for repeated Social Health Authority (SHA) pre-authorisations. This change will enable patients to access multiple treatment cycles with a single approval and utilize unified health records across contracted hospitals.
According to Kenya News Agency, the reforms are anticipated to facilitate healthcare access for 54,465 cancer patients currently under SHA treatment by minimizing administrative bottlenecks, lengthy hospital queues, treatment delays, and the financial burden associated with cancer care.
Cabinet Secretary for Health, Aden Duale, highlighted that these changes respond to longstanding issues raised by cancer patients and healthcare providers regarding repeated authorisations and fragmented care. The reforms are designed to reduce bureaucracy, improve care quality, and enhance financial protection for cancer patients.
The Ministry of Health, in collaboration with the Office of the Director-General for Health, has developed the National Cancer Control Protocol (NCCP), implemented digitally through the SHA Oncology Module. This new system ensures that pre-authorisations are patient-based, allowing flexibility in accessing treatment across any SHA-contracted hospital without repeated approvals.
The government has also increased the oncology benefit from Sh550,000 to Sh800,000 starting December 1, 2025, to strengthen financial protection for patients. Duale disclosed that SHA has paid healthcare facilities over Sh11.6 billion in oncology claims, emphasizing the government’s commitment to preventing illness from becoming a poverty sentence.
Efforts to expand access to cancer treatment include decentralizing services and investing in regional healthcare infrastructure. Six comprehensive cancer centers currently operate in major hospitals, with additional centers and oncology programs being developed in various counties.
Furthermore, partnerships with pharmaceutical companies like Pfizer and Roche have led to significant price reductions for cancer medicines, enhancing affordability for patients under SHA.
The Ministry of Health and SHA are set to address operational challenges in a consultative meeting with the Kenya Society of Haematology and Oncology (KESHO), as noted by KESHO President Dr. Gladwell Kiarie. She urged that policy commitments must lead to tangible improvements in patients’ experiences.
Dr. Catherine Nyongesa, Clinical Radiation Oncologist at Kenyatta National Hospital, welcomed the reforms, emphasizing the importance of digitization and standardization in improving patient care. She noted that patient records will now be accessible across facilities, ensuring continuity of care wherever patients seek treatment.